CHRONIC MYELOGENOUS LEUKEMIA FOLLOWING I$sup 131$ THERAPY FOR METASTATIC THYROID CARCINOMA. Report of a Case and Some Considerations of the Etiologic Factors

Journal Article · Mon May 01 04:00:00 EDT 1961 · Am. J. Roentgenol., Radium Therapy Nuclear Med.

OSTI ID:4090988

Ozarda, A; Ergin, U; Bender, M A

A case of chronic myelogenous leukemia was observed following I/sup 1// sup 3//sup 1/ therapy. There has been no previous report of such a case, although acute and subacute leukemia have been reported. The literature has been reviewed and some tentative relationships have been considered between ionizing radiations, particularly from I/sup 1//sup 3//sup 1/ therapy, and the incidence of leukemia. No definite statement can be made since other etiologic factors cannot be definitely ruled out and the number of reported cases is too small to draw any conclusion. Nevertheless, large doses of I/sup 1//sup 3//sup 1/ appear to be hazardous and may be leukemogenic. (auth)

• Research Organization: Rosswell Park Memorial Inst., Buffalo
• NSA Number: NSA-15-020558
• OSTI ID: 4090988
• Journal Information: Am. J. Roentgenol., Radium Therapy Nuclear Med., Journal Name: Am. J. Roentgenol., Radium Therapy Nuclear Med. Vol. Vol: 84
• Country of Publication: Country unknown/Code not available
• Language: English

Related Subjects

BIOLOGY AND MEDICINE
CANCER
GLANDS
IODINE 131
LEUKEMIA
MAN
MEDICINE
METASTASES
THERAPY
THYROID